Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.35 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | APLNR | P35414 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14087668 | 1.00 | CA1 (0.36) | CA1CA2CA7NOS1NOS3 | |
| SCHEMBL2687921 | 0.82 | NOS1 (0.38) | CA1CA2CA7NOS1NOS3 | |
| SCHEMBL19008049 | 0.82 | NOS1 (0.38) | CA1CA2CA7NOS1NOS3 | |
| SCHEMBL14593924 | 0.81 | CA1 (0.38) | CA1CA2CA7NOS1NOS3 | |
| SCHEMBL22080323 | 0.81 | CA1 (0.33) | CA1CA2CA7NOS1NOS3 | |
| SCHEMBL24719148 | 0.80 | NOS1 (0.37) | CA1CA2CA7NOS1NOS3 | |
| SCHEMBL18775065 | 0.79 | CA1 (0.33) | CA1CA2CA7NOS1NOS3 | |
| SCHEMBL20499832 | 0.79 | MMP8 (0.32) | MMP8 | |
| SCHEMBL16665545 | 0.79 | CA1 (0.37) | CA1CA2CA7NOS1NOS3 | |
| SCHEMBL12309460 | 0.79 | CA1 (0.37) | CA1CA2CA7NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9796641-B2 | Stabilization of radiosynthetic intermediates | TRASIS S.A. (BE) | 2017-10-24 | — | — | US | disclosed |
| US-20160075615-A1 | Stabilization of Radiosynthetic Intermediates | TRASIS S.A. (BE) | 2016-03-17 | — | — | US | disclosed |
| EP-2278399-B1 | Positive-working resist composition | FUJIFILM CORP (JP) | 2013-05-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075615-A1 | Stabilization of Radiosynthetic Intermediates | AADAT, RNF168, APEX1 | CA1 2392/4885CA2 4034/4885CA7 3012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.